SBI Healthcare Opportunities Fund - Dividend - Regular Plan

  • Previous Nav

  • Net Change on 23-09-2020

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Dividend | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN - DIVIDEND 1.20 17.87 55.30 11.77 3.45 15.85
S&P BSE Health Care 0.79 15.24 49.44 11.79 2.07 14.67
S&P BSE Health Care - TRI 0.82 15.56 50.49 12.54 2.73 14.27
S&P BSE SENSEX - TRI -1.97 6.89 -2.55 6.90 9.20 12.45

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN - DIVIDEND Jul 03, 1999 55.30 11.77 3.45 2.23 1,360.70
Nippon India Pharma Fund-Dividend-Dividend Jun 05, 2004 55.63 18.82 7.89 2.09 3,652.59
UTI Healthcare Fund - Regular Plan - Income Option Aug 25, 1999 59.07 15.04 5.36 2.81 563.44

Fund Holdings as on 31-August-2020

  • Sun Pharmaceutical Industries Ltd.

  • Lupin Ltd.

  • Cipla Ltd.

  • Aurobindo Pharma Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Divi's Laboratories Ltd.

  • Strides Pharma Science Ltd.

  • Narayana Hrudayalaya Ltd.

  • TREPS

  • Alkem Laboratories Ltd.

  • Thyrocare Technologies Ltd.

  • Abbott India Ltd.

  • Ajanta Pharma Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Sequent Scientific Ltd.

  • Alembic Pharmaceuticals Ltd.

  • Natco Pharma Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Gufic Biosciences Ltd.

  • Biocon Ltd.

  • Solara Active Pharma Sciences Ltd.

  • Pfizer Ltd.

  • Metropolis Healthcare Ltd.

  • Shreno Ltd.

  • Margin amount for Derivative positions

  • Net Receivable / Payable

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Diversified

View More

Fund Manager

  • Education:B.E (Electronics),MBA (Finance),C.F.A(USA) Level III candidate
  • Experience:6 years
  • Basic Details:Mr. Desai has close to 6 years of work experience with over 3 years of experience in Indian capital markets. He has been associated with SBI Funds Management Private Limited from May 2008. Prior to join SBI Funds Management Pvt. Ltd. he was a lecturer in Electronics Department with D J Sanghvi College of Engineering, Mumbai.
  • Funds Managed:
  • SBI Healthcare Opportunities Fund

Most Recent Dividend

  • 16/03/2018

  • 30/01/2015

  • 04/01/2005

  • 06/09/2004

  • 22/09/2003

  • Cash

  • Equity

  • Preference Shares

View More

About SBI Healthcare Opportunities Fund

Scheme Analysis

SBI Healthcare Opportunities Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to SBI Mutual Fund. It was launched on 03-Jul-1999 and currently has an AUM of ₹1,360.70 crore. SBI Healthcare Opportunities Fund is benchmarked against S&P BSE Health Care as primary index and S&P BSE Health Care - TRI as primary index and S&P BSE SENSEX - TRI as secondary index.

The NAV of SBI Healthcare Opportunities Fund ended down ₹-1.22(-1.11%)yesterday to ₹108.9789.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The SBI Healthcare Opportunities Fund is managed by Tanmaya Desai .

Fund House Contact

191, Maker Tower 'E' Cuffe Parade Mumbai - 400 005

022 - 22180221-27
022 - 22189663
www.sbimf.com